Vipik Pharma Private Limited

Pharmaceutical trading and distribution company based in Maharashtra.

2018 | Kolhapur, Maharashtra (India) | Active
Last Updated:

Vipik Pharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 7 Year, 16 Days
  • Last Filing with ROC 31 Mar 2020
  • Revenue Growth 188.31%
  • Profit Growth 55.23%
  • Ebitda 540.45%
  • Net Worth -0.61%
  • Total Assets 78.34%

About Vipik Pharma

Vipik Pharma Private Limited (VPPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 March 2018 (Seven years 16 days old ). Its registered office is in Kolhapur, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Vidyarani Salokhe, Sunanda Khot, Ganpati Patil, and One other member serve as directors at the Company.

Company Details

  • Location

    Kolhapur, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U51100PN2018PTC175054

  • Company No.

    175054

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    01 Mar 2018

  • Date of AGM

    31 Dec 2020

  • Date of Balance Sheet

    31 Mar 2020

  • Listing Status

    Unlisted

  • ROC Code

    Roc Pune

Industry

Pharma
Company report

Vipik Pharma Private Limited

Explore comprehensive data for Vipik Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Vipik Pharma?

Board Members (4)

NameDesignationAppointment DateStatus
Vidyarani Salokhe Country flag representing In Director 09-Mar-2018Current
Sunanda Khot Country flag representing In Director 01-Mar-2018Current
Ganpati Patil Country flag representing In Director 01-Mar-2018Current
Sunita Powar Country flag representing In Director 01-Mar-2018Current

Financial Performance of Vipik Pharma.

Vipik Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 188.31% increase. The company also saw a substantial improvement in profitability, with a 55.23% increase in profit. The company's net worth dipped by a decrease of 0.61%.

Vipik Pharma revenue growth over time
Vipik Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
188.31%
Revenue from Operations
188.31%
Total Assets
78.34%
Profit or Loss
55.23%
Net Worth
-0.61%
EBITDA
540.45%

What is the Ownership and Shareholding Structure of Vipik Pharma?

Unlock access to Vipik Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Vipik Pharma?

Unlock and access historical data on people associated with Vipik Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Vipik Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vipik Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vipik Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Vipik Pharma

Recent activity within the organization

  • Annual General Meeting

    Vipik Pharma Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.

  • Balance Sheet

    Vipik Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Pune.

  • Director Appointment

    Vidyarani Vinayak Salokhe was appointed as a Director was appointed as a Director on 09 Mar 2018 & has been associated with this company since 7 years 8 days .

  • Director Appointment

    Sunanda Vilas Khot was appointed as a Director was appointed as a Director on 01 Mar 2018 & has been associated with this company since 7 years 16 days .

  • Director Appointment

    Ganpati Chandu Patil was appointed as a Director was appointed as a Director on 01 Mar 2018 & has been associated with this company since 7 years 16 days .

  • Director Appointment

    Sunita Satappa Powar was appointed as a Director was appointed as a Director on 01 Mar 2018 & has been associated with this company since 7 years 16 days .

Frequently asked questions

  • What is the Incorporation or founding date of Vipik Pharma Private Limited?

    Vipik Pharma Private Limited was incorporated on 01 Mar 2018.

  • What is authorized share capital and paid-up capital of Vipik Pharma Private Limited?

    The authorized share capital of Vipik Pharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Who are the current board members & directors of Vipik Pharma Private Limited?

    Currently 4 directors are associated with Vipik Pharma Private Limited.

    • Vidyarani Vinayak Salokhe
    • Sunanda Vilas Khot
    • Ganpati Chandu Patil
    • Sunita Satappa Powar
  • What is the registered address of Vipik Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Vipik Pharma Private Limited is 733/6 2A Vidhyavihar Colony Somraj Complex, India, Kolhapur, Maharashtra, 416007.

  • What is the corporate identification number (CIN) and company number of Vipik Pharma Private Limited?

    The corporate identification number (CIN) of Vipik Pharma Private Limited is U51100PN2018PTC175054 and the company number is 175054 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Vipik Pharma Private Limited?

    According to the financial reports for the fiscal year 2020, the revenue trend for Vipik Pharma Private Limited has risen by 188.31%.

  • What change has been observed in the net worth of Vipik Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2020 indicates that The net worth of Vipik Pharma Private Limited has experienced an downturn of -0.61%.

  • When was the last Balance Sheet of Vipik Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Vipik Pharma Private Limited was filed with the ROC on 31 Mar 2020.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial